-- 
Creabilis Raises $19.8 Million in Second-Round Venture Funding

-- B y   P h i l   S e r a f i n o
-- 
2011-10-04T07:06:53Z

-- http://www.bloomberg.com/news/2011-10-04/creabilis-raises-19-8-million-in-second-round-venture-funding.html
Creabilis SA, a Luxembourg company
developing dermatology, inflammation and pain drugs, raised 15
million euros ($19.8 million) in second-round venture funding,
the company said.  Abbott Biotech Ventures led the funding, which also
included existing investors Neomed and Sofinnova Partners,
Creabilis said in an e-mailed statement today.,  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  